Central obesity and visceral adipose tissue are not associated with incident atherosclerotic cardiovascular disease events in older men

John T. Schousboe, Allyson M. Kats, Lisa Langsetmo, Tien N. Vo, Brent C. Taylor, Ann V. Schwartz, Peggy M. Cawthon, Cora E. Lewis, Elizabeth Barrett-Connor, Andrew R. Hoffman, Eric Orwoll, Kristine E. Ensrud

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background-Visceral adipose tissue (VAT) and other measures of central obesity predict incident atherosclerotic cardiovascular disease (ASCVD) events in middle-aged individuals, but these associations are less certain in older individuals age 70 years and older. Our objective was to estimate the associations of VAT and the android-gynoid fat mass ratio, another measure of central obesity, with incident ASCVD events among a large cohort of older men. Methods and Results-Two thousand eight hundred ninety-nine men (mean [SD] age 76.3 [5.5] years) enrolled in the Outcomes of Sleep Disorders in Older Men study had rigorous adjudication of incident ASCVD events (myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke). We used proportional hazards models to estimate the hazard ratios for incident ASCVD per SD increase of VAT or android-gynoid fat mass ratio (measured at baseline with dual-energy absorptiometry), adjusted for age, race, education, systolic blood pressure, smoking status, oxidized low-density lipoprotein level, treatment for hypertension, statin use, aspirin use, presence of diabetes mellitus, and study enrollment site. Over a mean (SD) follow-up period of 7.9 (3.4) years, 424 men (14.6%) had an incident ASCVD event. Neither VAT nor android-gynoid fat mass ratio were associated with incident ASCVD events, either unadjusted or after multivariable-adjustment (hazard ratios [95% confidence interval] per SD increase 1.02 [0.92-1.13] and 1.05 [0.95-1.17], respectively). Conclusions-Central adipose tissue, as measured by VAT or android-gynoid fat mass ratio, was not associated with incident ASCVD events in this study of older men.

Original languageEnglish (US)
Article numbere009172
JournalJournal of the American Heart Association
Volume7
Issue number16
DOIs
StatePublished - Aug 1 2018

Fingerprint

Intra-Abdominal Fat
Abdominal Obesity
Cardiovascular Diseases
Fats
Blood Pressure
Social Adjustment
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Proportional Hazards Models
Aspirin
Coronary Disease
Adipose Tissue
Diabetes Mellitus
Smoking
Stroke
Myocardial Infarction
Confidence Intervals
Hypertension
Education

Keywords

  • Android gynoid fat mass ratio
  • Cardiovascular outcomes
  • Central obesity
  • Dual energy x-ray absorptiometry
  • Visceral adipose tissue

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Central obesity and visceral adipose tissue are not associated with incident atherosclerotic cardiovascular disease events in older men. / Schousboe, John T.; Kats, Allyson M.; Langsetmo, Lisa; Vo, Tien N.; Taylor, Brent C.; Schwartz, Ann V.; Cawthon, Peggy M.; Lewis, Cora E.; Barrett-Connor, Elizabeth; Hoffman, Andrew R.; Orwoll, Eric; Ensrud, Kristine E.

In: Journal of the American Heart Association, Vol. 7, No. 16, e009172, 01.08.2018.

Research output: Contribution to journalArticle

Schousboe, JT, Kats, AM, Langsetmo, L, Vo, TN, Taylor, BC, Schwartz, AV, Cawthon, PM, Lewis, CE, Barrett-Connor, E, Hoffman, AR, Orwoll, E & Ensrud, KE 2018, 'Central obesity and visceral adipose tissue are not associated with incident atherosclerotic cardiovascular disease events in older men', Journal of the American Heart Association, vol. 7, no. 16, e009172. https://doi.org/10.1161/JAHA.118.009172
Schousboe, John T. ; Kats, Allyson M. ; Langsetmo, Lisa ; Vo, Tien N. ; Taylor, Brent C. ; Schwartz, Ann V. ; Cawthon, Peggy M. ; Lewis, Cora E. ; Barrett-Connor, Elizabeth ; Hoffman, Andrew R. ; Orwoll, Eric ; Ensrud, Kristine E. / Central obesity and visceral adipose tissue are not associated with incident atherosclerotic cardiovascular disease events in older men. In: Journal of the American Heart Association. 2018 ; Vol. 7, No. 16.
@article{4c9b05b53b0c4684a45b951dd18d2e7d,
title = "Central obesity and visceral adipose tissue are not associated with incident atherosclerotic cardiovascular disease events in older men",
abstract = "Background-Visceral adipose tissue (VAT) and other measures of central obesity predict incident atherosclerotic cardiovascular disease (ASCVD) events in middle-aged individuals, but these associations are less certain in older individuals age 70 years and older. Our objective was to estimate the associations of VAT and the android-gynoid fat mass ratio, another measure of central obesity, with incident ASCVD events among a large cohort of older men. Methods and Results-Two thousand eight hundred ninety-nine men (mean [SD] age 76.3 [5.5] years) enrolled in the Outcomes of Sleep Disorders in Older Men study had rigorous adjudication of incident ASCVD events (myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke). We used proportional hazards models to estimate the hazard ratios for incident ASCVD per SD increase of VAT or android-gynoid fat mass ratio (measured at baseline with dual-energy absorptiometry), adjusted for age, race, education, systolic blood pressure, smoking status, oxidized low-density lipoprotein level, treatment for hypertension, statin use, aspirin use, presence of diabetes mellitus, and study enrollment site. Over a mean (SD) follow-up period of 7.9 (3.4) years, 424 men (14.6{\%}) had an incident ASCVD event. Neither VAT nor android-gynoid fat mass ratio were associated with incident ASCVD events, either unadjusted or after multivariable-adjustment (hazard ratios [95{\%} confidence interval] per SD increase 1.02 [0.92-1.13] and 1.05 [0.95-1.17], respectively). Conclusions-Central adipose tissue, as measured by VAT or android-gynoid fat mass ratio, was not associated with incident ASCVD events in this study of older men.",
keywords = "Android gynoid fat mass ratio, Cardiovascular outcomes, Central obesity, Dual energy x-ray absorptiometry, Visceral adipose tissue",
author = "Schousboe, {John T.} and Kats, {Allyson M.} and Lisa Langsetmo and Vo, {Tien N.} and Taylor, {Brent C.} and Schwartz, {Ann V.} and Cawthon, {Peggy M.} and Lewis, {Cora E.} and Elizabeth Barrett-Connor and Hoffman, {Andrew R.} and Eric Orwoll and Ensrud, {Kristine E.}",
year = "2018",
month = "8",
day = "1",
doi = "10.1161/JAHA.118.009172",
language = "English (US)",
volume = "7",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "16",

}

TY - JOUR

T1 - Central obesity and visceral adipose tissue are not associated with incident atherosclerotic cardiovascular disease events in older men

AU - Schousboe, John T.

AU - Kats, Allyson M.

AU - Langsetmo, Lisa

AU - Vo, Tien N.

AU - Taylor, Brent C.

AU - Schwartz, Ann V.

AU - Cawthon, Peggy M.

AU - Lewis, Cora E.

AU - Barrett-Connor, Elizabeth

AU - Hoffman, Andrew R.

AU - Orwoll, Eric

AU - Ensrud, Kristine E.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Background-Visceral adipose tissue (VAT) and other measures of central obesity predict incident atherosclerotic cardiovascular disease (ASCVD) events in middle-aged individuals, but these associations are less certain in older individuals age 70 years and older. Our objective was to estimate the associations of VAT and the android-gynoid fat mass ratio, another measure of central obesity, with incident ASCVD events among a large cohort of older men. Methods and Results-Two thousand eight hundred ninety-nine men (mean [SD] age 76.3 [5.5] years) enrolled in the Outcomes of Sleep Disorders in Older Men study had rigorous adjudication of incident ASCVD events (myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke). We used proportional hazards models to estimate the hazard ratios for incident ASCVD per SD increase of VAT or android-gynoid fat mass ratio (measured at baseline with dual-energy absorptiometry), adjusted for age, race, education, systolic blood pressure, smoking status, oxidized low-density lipoprotein level, treatment for hypertension, statin use, aspirin use, presence of diabetes mellitus, and study enrollment site. Over a mean (SD) follow-up period of 7.9 (3.4) years, 424 men (14.6%) had an incident ASCVD event. Neither VAT nor android-gynoid fat mass ratio were associated with incident ASCVD events, either unadjusted or after multivariable-adjustment (hazard ratios [95% confidence interval] per SD increase 1.02 [0.92-1.13] and 1.05 [0.95-1.17], respectively). Conclusions-Central adipose tissue, as measured by VAT or android-gynoid fat mass ratio, was not associated with incident ASCVD events in this study of older men.

AB - Background-Visceral adipose tissue (VAT) and other measures of central obesity predict incident atherosclerotic cardiovascular disease (ASCVD) events in middle-aged individuals, but these associations are less certain in older individuals age 70 years and older. Our objective was to estimate the associations of VAT and the android-gynoid fat mass ratio, another measure of central obesity, with incident ASCVD events among a large cohort of older men. Methods and Results-Two thousand eight hundred ninety-nine men (mean [SD] age 76.3 [5.5] years) enrolled in the Outcomes of Sleep Disorders in Older Men study had rigorous adjudication of incident ASCVD events (myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke). We used proportional hazards models to estimate the hazard ratios for incident ASCVD per SD increase of VAT or android-gynoid fat mass ratio (measured at baseline with dual-energy absorptiometry), adjusted for age, race, education, systolic blood pressure, smoking status, oxidized low-density lipoprotein level, treatment for hypertension, statin use, aspirin use, presence of diabetes mellitus, and study enrollment site. Over a mean (SD) follow-up period of 7.9 (3.4) years, 424 men (14.6%) had an incident ASCVD event. Neither VAT nor android-gynoid fat mass ratio were associated with incident ASCVD events, either unadjusted or after multivariable-adjustment (hazard ratios [95% confidence interval] per SD increase 1.02 [0.92-1.13] and 1.05 [0.95-1.17], respectively). Conclusions-Central adipose tissue, as measured by VAT or android-gynoid fat mass ratio, was not associated with incident ASCVD events in this study of older men.

KW - Android gynoid fat mass ratio

KW - Cardiovascular outcomes

KW - Central obesity

KW - Dual energy x-ray absorptiometry

KW - Visceral adipose tissue

UR - http://www.scopus.com/inward/record.url?scp=85052370464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052370464&partnerID=8YFLogxK

U2 - 10.1161/JAHA.118.009172

DO - 10.1161/JAHA.118.009172

M3 - Article

VL - 7

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 16

M1 - e009172

ER -